India to Philippines: Rituximab Export Trade Route
India has recorded 12 verified shipments of Rituximab exported to Philippines, representing a combined trade value of $383.0K USD. This corridor is served by 6 active Indian exporters, with an average shipment value of $31.9K USD. The leading Indian exporter is DR.REDDY'S LABORATORIES LTD, which accounts for 94% of total export value with 7 shipments worth $358.7K USD. On the buying side, DR.REDDYS LABORATORIES PHILIPPINES is the largest importer in Philippines with $368.9K USD in purchases. The top 3 suppliers — DR.REDDY'S LABORATORIES LTD, DR REDDY S LABORATORIES LTD, DR.REDDY'S LABORATORIES LIMITED — together control 99% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Philippines Rituximab corridor is one of India's established pharmaceutical export routes, with 12 shipments documented worth a combined $383.0K USD. The route is dominated by DR.REDDY'S LABORATORIES LTD, which alone accounts for roughly 94% of all export value, reflecting the consolidated nature of India's rituximab manufacturing sector.
Across 6 active suppliers, the average shipment value stands at $31.9K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 80% of all shipments, consistent with rituximab's non-urgent bulk-order profile.
Shipment activity peaks during January–March, with an average transit time of 19 days port-to-port. The route has recorded an annual growth rate of 17.4%, placing it at rank #11 among India's top rituximab export destinations globally.
On the import side, key buyers of Indian rituximab in Philippines include DR.REDDYS LABORATORIES PHILIPPINES, DR REDDYS LABORATORIES PHILIPPINES, CLIENT CODE PH001 and 2 others. DR.REDDYS LABORATORIES PHILIPPINES is the single largest importer with 8 shipments valued at $368.9K USD.
Route Characteristics
- Average transit19 days
- Peak seasonQ1
- Primary modeSea freight
- Top portHYDERABAD AIR
Market Position
- Global rank#11
- Annual growth+17.4%
- Demand growth+16.8%
- Regulatory ease84/100
Top 10 Indian Rituximab Exporters to Philippines
Showing top 10 of 6 Indian suppliers exporting Rituximab to Philippines, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | DR.REDDY'S LABORATORIES LTD Avg $51.2K per shipment | 7 | $358.7K | 93.7% |
| 2 | DR REDDY S LABORATORIES LTD Avg $10.2K per shipment | 1 | $10.2K | 2.7% |
| 3 | DR.REDDY'S LABORATORIES LIMITED Avg $10.1K per shipment | 1 | $10.1K | 2.6% |
| 4 | SANSKRUTI PHARMA Avg $2.9K per shipment | 1 | $2.9K | 0.8% |
| 5 | MALLESHWAR SPECIALITIES Avg $879 per shipment | 1 | $879 | 0.2% |
| 6 | YARAPMIN LIFECARE Avg $173 per shipment | 1 | $173 | 0.0% |
This table shows the top 10 of 6 Indian companies exporting rituximab to Philippines, ranked by total trade value. The listed exporters are: DR.REDDY'S LABORATORIES LTD, DR REDDY S LABORATORIES LTD, DR.REDDY'S LABORATORIES LIMITED, SANSKRUTI PHARMA, MALLESHWAR SPECIALITIES, YARAPMIN LIFECARE . DR.REDDY'S LABORATORIES LTD is the dominant supplier with 7 shipments worth $358.7K USD, giving it a 94% market share. The top 3 suppliers together account for 99% of the total trade value on this route.
Top 10 Rituximab Importers in Philippines
Showing top 10 of 5 known buyers in Philippines receiving Rituximab shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian rituximab in Philippines include DR.REDDYS LABORATORIES PHILIPPINES, DR REDDYS LABORATORIES PHILIPPINES, CLIENT CODE PH001, RENATO C LOZADA, CUSTOMER NUMBER.: YL-0090 . The largest importer is DR.REDDYS LABORATORIES PHILIPPINES, accounting for $368.9K USD across 8 shipments — representing 96% of all rituximab imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | DR.REDDYS LABORATORIES PHILIPPINES | 8 | $368.9K | 96.3% |
| 2 | DR REDDYS LABORATORIES PHILIPPINES | 1 | $10.2K | 2.7% |
| 3 | CLIENT CODE PH001 | 1 | $2.9K | 0.8% |
| 4 | RENATO C LOZADA | 1 | $879 | 0.2% |
| 5 | CUSTOMER NUMBER.: YL-0090 | 1 | $173 | 0.0% |
Top 10 Rituximab Formulations Imported by Philippines
Showing top 10 of 11 product formulations shipped on the India to Philippines Rituximab route, ranked by trade value
Philippines imports a wide range of rituximab formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — REDDITUX 10MG/MLCONCENTRATE FOR SOLUTIONFOR INFUSION(IV)(RITUXIMAB)(50 ML PER VIAL)(QTY:1900 VIALS) — accounts for $182.2K USD across 1 shipments. There are 11 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | REDDITUX 10MG/MLCONCENTRATE FOR SOLUTIONFOR INFUSION(IV)(RITUXIMAB)(50 ML PER VIAL)(QTY:1900 VIALS) | 1 | $182.2K | 47.6% |
| 2 | REDDITUX 10MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION(IV)(RITUXIMAB)(50 ML PERVIAL)(QTY:500 VIALS) | 1 | $47.5K | 12.4% |
| 3 | REDDITUX 500 MG(REDDITUX 10MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION(IV)RITUXIMAB(50 ML PER VIAL)(QTY:500 VIALS) | 1 | $47.2K | 12.3% |
| 4 | REDDITUX 10MG/MLCONCENTRATE FOR SOLUTIONFOR INFUSION(IV)(RITUXIMAB)10 ML PER VIAL)(QTY:2000 VIALS) | 1 | $42.1K | 11.0% |
| 5 | REDDITUX 10MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION(IV)(RITUXIMAB)(10 ML PERVIAL)(QTY:500 VIALS) | 2 | $20.6K | 5.4% |
| 6 | REDDITUX 500MG(RITUXIMAB)(QTY:200 VIALS)VLS | 1 | $19.1K | 5.0% |
| 7 | REDDITUX 100MG(REDDITUX 10MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION(IV)RITUXIMAB)(10 ML PER VIAL)(QTY:500 VIALS) | 1 | $10.3K | 2.7% |
| 8 | REDDITUX 100MG REDDITUX 10MG ML CONCENTRATE FOR SOLUTION FOR INFUSION IV RITUXIMAB 10 ML PER VIAL QTY 500 VIALS | 1 | $10.2K | 2.7% |
| 9 | MABTAS 500 (RITUXIMAB 500MG INJECTION) , PACK - VIAL | 1 | $2.9K | 0.8% |
| 10 | ENFIERA 100MG INJ RITUXIMAB INJ 100MG RA2431A | 1 | $879 | 0.2% |
Showing top 10 of 11 Rituximab formulations imported by Philippines on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 80%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
HYDERABAD AIR handles the highest volume with 6 shipments. Transit time averages 19 days by sea.
Market Dynamics
India's rituximab exports to Philippines are driven primarily by a handful of large-scale manufacturers. DR.REDDY'S LABORATORIES LTD with 7 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 6 active exporters signals a competitive but concentrated market — buyers in Philippines benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — DR.REDDY'S LABORATORIES LTD, DR REDDY S LABORATORIES LTD, DR.REDDY'S LABORATORIES LIMITED — together account for 99% of total trade value on this route. The average shipment value of $31.9K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as redditux 10mg/ml concentrate for solution for infusion(iv)(rituximab)(50 ml pervial)(qty:500 vials) and redditux 500 mg(redditux 10mg/ml concentrate for solution for infusion(iv)rituximab(50 ml per vial)(qty:500 vials), suggesting that buyers in Philippines tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, DR.REDDYS LABORATORIES PHILIPPINES is the largest importer with 8 shipments worth $368.9K USD — representing 96% of all rituximab imports from India on this route.
Route Statistics
- Trade Volume
- $383.0K
- Avg. Shipment
- $31.9K
- Suppliers
- 6
- Buyers
- 5
- Transit (Sea)
- ~19 days
- Annual Growth
- +17.4%
Other Rituximab Routes
Unlock the Full India to Philippines Rituximab Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 12 shipments on this route.
Frequently Asked Questions — India to Philippines Rituximab Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Rituximab to Philippines?
The leading Indian exporters of Rituximab to Philippines are DR.REDDY'S LABORATORIES LTD, DR REDDY S LABORATORIES LTD, DR.REDDY'S LABORATORIES LIMITED. DR.REDDY'S LABORATORIES LTD holds the largest market share at approximately 94% of total trade value on this route.
Q What is the total value of Rituximab exports from India to Philippines?
India exports Rituximab to Philippines worth approximately $383.0K USD across 12 recorded shipments. The average value per shipment is $31.9K USD.
Q Which ports does India use to ship Rituximab to Philippines?
The most active port of origin is HYDERABAD AIR with 6 shipments. Indian exporters primarily use sea freight for this route, with 80% of shipments going by sea and 26% by air.
Q How long does shipping take from India to Philippines for Rituximab?
The average transit time for Rituximab shipments from India to Philippines is approximately 19 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during January–March.
Q Is the India to Philippines Rituximab trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 17.4% with demand growth tracking at 16.8%. The route is ranked #11 among India's top Rituximab export destinations globally.
Q How many suppliers are active on the India to Philippines Rituximab route?
There are currently 6 active Indian suppliers exporting Rituximab to Philippines. The market is moderately concentrated with DR.REDDY'S LABORATORIES LTD accounting for 94% of total shipment value.
Q Who are the main importers of Rituximab from India in Philippines?
The leading importers of Indian Rituximab in Philippines include DR.REDDYS LABORATORIES PHILIPPINES, DR REDDYS LABORATORIES PHILIPPINES, CLIENT CODE PH001, RENATO C LOZADA, CUSTOMER NUMBER.: YL-0090 . DR.REDDYS LABORATORIES PHILIPPINES is the largest buyer with 8 shipments worth $368.9K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Philippines export trade corridor identified from Indian Customs (DGFT) records for Rituximab.
- 2.Supplier/Buyer Matching: 6 Indian exporters and 5 importers in Philippines matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 12 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
12 Verified Shipments
6 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists